Cardiometabolic risk: a Framingham perspective

被引:48
作者
Wilson, P. W. F. [1 ]
Meigs, J. B. [2 ]
机构
[1] Emory Univ, Sch Med, EPICORE, Atlanta, GA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
insulin resistance; diabetes mellitus; coronary artery disease;
D O I
10.1038/ijo.2008.30
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To review published data on vascular disease- and diabetes-related outcomes related to adiposity and metabolic risk factors. Design: Community cohort study with cross-sectional and prospective data. Subjects: Middle-aged Caucasian adults in a suburban environment. Measurements: Traditional risk factors for cardiovascular disease and the type 2 diabetes mellitus, as well as measures of insulin resistance, left ventricular hypertrophy and vascular calcification. Results: The cardiometabolic risk factors cluster in the population and a common core that includes adiposity (both waist and body mass index), abnormal lipids (both HDL cholesterol and triglycerides), and abnormal glucose and insulin metabolism was found to be present in Framingham participants. Increased insulin resistance was also found to be associated with coronary artery calcification and left ventricular hypertrophy in women. Analyses of the metabolic syndrome risk factors showed that a greater burden of risk factors was associated with greater risk of both cardiovascular disease and diabetes mellitus. An equation to estimate risk of developing type 2 diabetes mellitus has been developed from the Framingham experience, and the risk factors included in the metabolic syndrome are key components, including increased waist girth, elevated blood pressure, low HDL cholesterol, high triglycerides and impaired fasting glucose. Conclusion: Cardiometabolic factors and insulin resistance are important contributors to the development of type 2 diabetes mellitus, subclinical cardiovascular disease and clinical cardiovascular disease.
引用
收藏
页码:S17 / S20
页数:4
相关论文
共 11 条
  • [1] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [2] Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
    Ford, ES
    [J]. DIABETES CARE, 2005, 28 (07) : 1769 - 1778
  • [3] The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
    Lakka, HM
    Laaksonen, DE
    Lakka, TA
    Niskanen, LK
    Kumpusalo, E
    Tuomilehto, J
    Salonen, JT
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21): : 2709 - 2716
  • [4] The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
    McNeill, AM
    Schmidt, MI
    Rosamond, WD
    East, HE
    Girman, CJ
    Ballantyne, CM
    Golden, SH
    Heiss, G
    [J]. DIABETES CARE, 2005, 28 (02) : 385 - 390
  • [5] Risk variable clustering in the insulin resistance syndrome - The Framingham Offspring Study
    Meigs, JB
    DAgostino, RB
    Wilson, PWF
    Cupples, LA
    Nathan, DM
    Singer, DE
    [J]. DIABETES, 1997, 46 (10) : 1594 - 1600
  • [6] Coronary artery calcification in type 2 diabetes and insulin resistance - The Framingham Offspring Study
    Meigs, JB
    Larson, MG
    D'Agostino, RB
    Levy, D
    Clouse, ME
    Nathan, DM
    Wilson, PWF
    O'Donnell, CJ
    [J]. DIABETES CARE, 2002, 25 (08) : 1313 - 1319
  • [7] Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance - The Framingham Offspring Study
    Meigs, JB
    Nathan, DM
    Wilson, PWF
    Cupples, LA
    Singer, DE
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) : 524 - +
  • [8] Impact of glucose intolerance and insulin resistance on cardiac structure and function - Sex-related differences in the Framingham Heart Study
    Rutter, MK
    Parise, H
    Benjamin, EJ
    Levy, D
    Larson, MG
    Meigs, JB
    Nesto, RW
    Wilson, PWF
    Vasan, RS
    [J]. CIRCULATION, 2003, 107 (03) : 448 - 454
  • [9] Prediction of incident diabetes mellitus in middle-aged adults - The Framingham Offspring Study
    Wilson, Peter W. F.
    Meigs, James B.
    Sullivan, Lisa
    Fox, Caroline S.
    Nathan, David M.
    D'Agostino, Ralph B., Sr.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (10) : 1068 - 1074
  • [10] Clustering of metabolic factors and coronary heart disease
    Wilson, PWF
    Kannel, WB
    Silbershatz, H
    D'Agostino, RB
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1104 - 1109